Paying users zone. Data is covered by hidden.

  • Get 1 month access to Johnson & Johnson for $19.99, or

  • get full access to entire website for at least 3 months from $49.99.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

Microsoft Excel LibreOffice Calc

Johnson & Johnson (JNJ)


Long-term (Investment) Activity Analysis

Difficulty: Beginner


Ratios (Summary)

Johnson & Johnson, long-term (investment) activity ratios

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Net fixed asset turnover hidden hidden hidden hidden hidden
Total asset turnover hidden hidden hidden hidden hidden
Equity turnover hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Johnson & Johnson’s net fixed asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Johnson & Johnson’s total asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Johnson & Johnson’s equity turnover improved from 2016 to 2017 and from 2017 to 2018.

Net Fixed Asset Turnover

Johnson & Johnson, net fixed asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Sales to customers hidden hidden hidden hidden hidden
Property, plant and equipment, net hidden hidden hidden hidden hidden
Ratio
Net fixed asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Net Fixed Asset Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Net Fixed Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Net fixed asset turnover = Sales to customers ÷ Property, plant and equipment, net
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Net fixed asset turnover An activity ratio calculated as total revenue divided by net fixed assets. Johnson & Johnson’s net fixed asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Total Asset Turnover

Johnson & Johnson, total asset turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Sales to customers hidden hidden hidden hidden hidden
Total assets hidden hidden hidden hidden hidden
Ratio
Total asset turnover1 hidden hidden hidden hidden hidden
Benchmarks
Total Asset Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Total Asset Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Total Asset Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Total asset turnover = Sales to customers ÷ Total assets
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Total asset turnover An activity ratio calculated as total revenue divided by total assets. Johnson & Johnson’s total asset turnover deteriorated from 2016 to 2017 but then improved from 2017 to 2018 exceeding 2016 level.

Equity Turnover

Johnson & Johnson, equity turnover calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Sales to customers hidden hidden hidden hidden hidden
Shareholders’ equity hidden hidden hidden hidden hidden
Ratio
Equity turnover1 hidden hidden hidden hidden hidden
Benchmarks
Equity Turnover, Competitors2
Abbott Laboratories hidden hidden hidden hidden hidden
AbbVie Inc. hidden hidden hidden hidden hidden
Allergan PLC hidden hidden hidden hidden hidden
Amgen Inc. hidden hidden hidden hidden hidden
Biogen Inc. hidden hidden hidden hidden hidden
Bristol-Myers Squibb Co. hidden hidden hidden hidden hidden
Celgene Corp. hidden hidden hidden hidden hidden
Eli Lilly & Co. hidden hidden hidden hidden hidden
Gilead Sciences Inc. hidden hidden hidden hidden hidden
Merck & Co. Inc. hidden hidden hidden hidden hidden
Pfizer Inc. hidden hidden hidden hidden hidden
Regeneron Pharmaceuticals Inc. hidden hidden hidden hidden hidden
Equity Turnover, Sector
Pharmaceuticals & Biotechnology hidden hidden hidden hidden hidden
Equity Turnover, Industry
Health Care hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Equity turnover = Sales to customers ÷ Shareholders’ equity
= hidden ÷ hidden = hidden

2 Click competitor name to see calculations.

Ratio Description The company
Equity turnover An activity ratio calculated as total revenue divided by shareholders’ equity. Johnson & Johnson’s equity turnover improved from 2016 to 2017 and from 2017 to 2018.